{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T01:06:27Z","timestamp":1775523987611,"version":"3.50.1"},"reference-count":106,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Endodontics"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1016\/j.joen.2014.08.013","type":"journal-article","created":{"date-parts":[[2014,10,9]],"date-time":"2014-10-09T07:23:11Z","timestamp":1412839391000},"page":"1902-1911","source":"Crossref","is-referenced-by-count":47,"title":["An Overview on Biologic Medications and Their Possible Role in Apical Periodontitis"],"prefix":"10.1016","volume":"40","author":[{"given":"Elisabetta","family":"Cotti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9916-9524","authenticated-orcid":false,"given":"Elia","family":"Schirru","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elio","family":"Acquas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paolo","family":"Usai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.joen.2014.08.013_bib1","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1177\/154411130401500604","article-title":"Pathogenesis of apical periodontitis and the causes of endodontic failures","volume":"15","author":"Nair","year":"2004","journal-title":"Crit Rev Oral Biol Med"},{"key":"10.1016\/j.joen.2014.08.013_bib2","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.tripleo.2004.06.065","article-title":"Factors affecting the outcome of orthograde root canal therapy in a general dentistry hospital practice","volume":"99","author":"Marending","year":"2005","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"10.1016\/j.joen.2014.08.013_bib3","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/j.1365-2591.2008.01484.x","article-title":"Outcome of primary root canal treatment: a systematic review of the literature\u2014part 2. Influence of clinical factors","volume":"41","author":"Ng","year":"2008","journal-title":"Int Endod J"},{"key":"10.1016\/j.joen.2014.08.013_bib4","first-page":"1","article-title":"The dependence of the results of pulp therapy on certain factors. An analytical study based on radiographic and clinical follow-up examinations","volume":"14","author":"Strindberg","year":"1956","journal-title":"Acta Odontol Scand"},{"key":"10.1016\/j.joen.2014.08.013_bib5","doi-asserted-by":"crossref","first-page":"43","DOI":"10.14219\/jada.archive.2003.0016","article-title":"The effect of diabetes mellitus on endodontic treatment outcome: data from an electronic patient record","volume":"134","author":"Fouad","year":"2003","journal-title":"J Am Dent Assoc"},{"key":"10.1016\/j.joen.2014.08.013_bib6","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/00004770-200201000-00003","article-title":"Periapical lesion progression with controlled microbial inoculation in a type I diabetic mouse model","volume":"28","author":"Fouad","year":"2002","journal-title":"J Endod"},{"key":"10.1016\/j.joen.2014.08.013_bib7","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/S0099-2399(96)80243-3","article-title":"Periapical lesions in rats with streptozocin-induced diabetes","volume":"22","author":"Konsaka","year":"1996","journal-title":"J Endod"},{"key":"10.1016\/j.joen.2014.08.013_bib8","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.joen.2008.11.019","article-title":"Healing kinetics of periapical lesions enhanced by the apexum procedure: a clinical trial","volume":"35","author":"Metzger","year":"2009","journal-title":"J Endod"},{"key":"10.1016\/j.joen.2014.08.013_bib9","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1111\/j.1365-2591.2007.01272.x","article-title":"Association of CD 14, IL1B, IL6, IL10 and TNFA functional gene polymorphisms with symptomatic dental abscesses","volume":"20","author":"De Sa","year":"2007","journal-title":"Int Endod J"},{"key":"10.1016\/j.joen.2014.08.013_bib10","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.joen.2011.01.009","article-title":"Genetic predisposition to persistent apical periodontitis","volume":"37","author":"Morsani","year":"2011","journal-title":"J Endod"},{"key":"10.1016\/j.joen.2014.08.013_bib11","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1111\/j.1365-2362.1992.tb01480.x","article-title":"A Taq I Polymorphism in the human interleukin-1 beta (IL-1 beta) gene correlates with IL-1 beta secretion in\u00a0vitro","volume":"22","author":"Pociot","year":"1992","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.joen.2014.08.013_bib12","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.joen.2011.12.022","article-title":"Postorthodontic external root resorption in root-filled teeth is influenced by interleukin-1b polymorphism","volume":"38","author":"Iglesias-Linares","year":"2012","journal-title":"J Endod"},{"key":"10.1016\/j.joen.2014.08.013_bib13","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/j.1365-2249.2006.03261.x","article-title":"Chronic inflammation: importance of Nod2 And Nalp3 in interleukin-1\u03b2 generation","volume":"147","author":"Ferrero-Miliani","year":"2007","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.joen.2014.08.013_bib14","series-title":"Robbins and Cotran Pathologic Basis Of Disease","author":"Kumar","year":"2010"},{"key":"10.1016\/j.joen.2014.08.013_bib15","series-title":"Rubin\u2019s Pathology: Clinicopathologic Foundations of Medicine","author":"Rubin","year":"2011"},{"key":"10.1016\/j.joen.2014.08.013_bib16","series-title":"Seltzer and Bender\u2019s Dental Pulp","author":"Hargreaves","year":"2012"},{"key":"10.1016\/j.joen.2014.08.013_bib17","first-page":"907","article-title":"Chemokines and their receptors in disease","volume":"20","author":"Bendall","year":"2005","journal-title":"Histol Histopathol"},{"key":"10.1016\/j.joen.2014.08.013_bib18","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1182\/blood-2012-06-437392","article-title":"Platelet serotonin promotes the recruitment of neutrophils to sites of acute inflammation in mice","volume":"121","author":"Duerschmied","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.joen.2014.08.013_bib19","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1016\/j.pain.2012.06.018","article-title":"Sex differences in serotonin enhancement of capsaicin-evoked calcitonin gene-related peptide release from human dental pulp","volume":"153","author":"Loyd","year":"2012","journal-title":"Pain"},{"key":"10.1016\/j.joen.2014.08.013_bib20","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1111\/j.1747-4477.2009.00160.x","article-title":"The relationship of pulp polyp with the presence and concentration of immunoglobulin E, histamine, interleukin-4 and interleukin-12","volume":"35","author":"Sattari","year":"2009","journal-title":"Aust Endod J"},{"key":"10.1016\/j.joen.2014.08.013_bib21","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/path.2287","article-title":"TNF-mediated inflammatory disease","volume":"2014","author":"Bradley","year":"2008","journal-title":"J Pathol"},{"key":"10.1016\/j.joen.2014.08.013_bib22","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/sj.cdd.4401189","article-title":"Tumor necrosis factor signaling","volume":"10","author":"Wajant","year":"2003","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.joen.2014.08.013_bib23","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.cytogfr.2003.10.005","article-title":"IL-6, RANKL, TNF-alpha\/IL-1: interrelations in bone resorption pathophysiology","volume":"15","author":"Steeve","year":"2004","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.joen.2014.08.013_bib24","series-title":"Inflammation: Basic Principles and Clinical Correlates","author":"Gallin","year":"1999"},{"key":"10.1016\/j.joen.2014.08.013_bib25","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.jaci.2010.11.050","article-title":"Interleukins, from 1 to 37, and interferon-\u03b3: receptors, functions, and roles in diseases","volume":"127","author":"Akdis","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.joen.2014.08.013_bib26","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0003-9969(98)00094-6","article-title":"Expression of bone-resorptive and regulatory cytokines in murine periapical inflammation","volume":"44","author":"Kawashima","year":"1999","journal-title":"Arch Oral Biol"},{"key":"10.1016\/j.joen.2014.08.013_bib27","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/S0099-2399(98)80089-7","article-title":"Balance of interleukin-1\u03b2 and interleukin-1 receptor antagonist in human periapical lesions","volume":"24","author":"Shimauchi","year":"1998","journal-title":"J Endod"},{"key":"10.1016\/j.joen.2014.08.013_bib28","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1097\/00004770-200209000-00006","article-title":"Evaluating IL-2 levels in human pulp tissue","volume":"28","author":"Anderson","year":"2002","journal-title":"J Endod"},{"key":"10.1016\/j.joen.2014.08.013_bib29","doi-asserted-by":"crossref","first-page":"3626","DOI":"10.4049\/jimmunol.165.7.3626","article-title":"IL-10, but not IL-4, suppresses infection-stimulated bone resorption in\u00a0vivo","volume":"165","author":"Sasaki","year":"2000","journal-title":"J Immunol"},{"key":"10.1016\/j.joen.2014.08.013_bib30","doi-asserted-by":"crossref","first-page":"327417","DOI":"10.1155\/2010\/327417","article-title":"A controversial role for IL-12 in immune response and bone resorption at apical periodontal sites","volume":"2010","author":"Queiroz-Junior","year":"2010","journal-title":"Clin Dev Immunol"},{"key":"10.1016\/j.joen.2014.08.013_bib31","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.joen.2007.01.002","article-title":"Update on the adaptive immune responses of the dental pulp","volume":"33","author":"Hahn","year":"2007","journal-title":"J Endod"},{"issue":"3","key":"10.1016\/j.joen.2014.08.013_bib32","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.cyto.2008.07.017","article-title":"An overview of IL-17 function and signaling","volume":"43","author":"Gaffen","year":"2008","journal-title":"Cytokine"},{"key":"10.1016\/j.joen.2014.08.013_bib33","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.molimm.2009.01.011","article-title":"Proinflammatory and immunoregulatory mechanisms in periapical lesions","volume":"47","author":"Coli\u0107","year":"2009","journal-title":"Mol Immunol"},{"key":"10.1016\/j.joen.2014.08.013_bib34","doi-asserted-by":"crossref","first-page":"d12","DOI":"10.2741\/A171","article-title":"Cytokines in acute and chronic inflammation","volume":"2","author":"Feghali","year":"1997","journal-title":"Front Biosci"},{"key":"10.1016\/j.joen.2014.08.013_bib35","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/S1079-2104(03)00067-2","article-title":"Immunolocalization of interleukin 4, interleukin 6, and lymphotoxin \u03b1 in dental granulomas","volume":"96","author":"de Sa","year":"2003","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"10.1016\/j.joen.2014.08.013_bib36","series-title":"Fundamentals of Inflammation","author":"Serhan","year":"2010"},{"key":"10.1016\/j.joen.2014.08.013_bib37","series-title":"Cohen's Pathways of the Pulp Expert Consult","first-page":"529","article-title":"Pathobiology of the periapex","author":"Lin","year":"2011"},{"key":"10.1016\/j.joen.2014.08.013_bib38","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.joen.2007.01.001","article-title":"Innate immune responses of the dental pulp to caries","volume":"33","author":"Hahn","year":"2007","journal-title":"J Endod"},{"key":"10.1016\/j.joen.2014.08.013_bib39","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.joen.2011.12.010","article-title":"T-lymphocyte and cytokine expression in human inflammatory periapical lesions","volume":"38","author":"de Brito","year":"2012","journal-title":"J Endod"},{"key":"10.1016\/j.joen.2014.08.013_bib40","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.joen.2012.02.021","article-title":"Correlation between clinical\/radiographic features and inflammatory cytokine networks produced by macrophages stimulated with endodontic content","volume":"38","author":"Martinho","year":"2012","journal-title":"J Endod"},{"key":"10.1016\/j.joen.2014.08.013_bib41","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.joen.2013.10.022","article-title":"Signaling pathways activation by primary endodontic infectious contents and production of inflammatory mediators","volume":"40","author":"Martinho","year":"2014","journal-title":"J Endod"},{"key":"10.1016\/j.joen.2014.08.013_bib42","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/j.1600-065X.1984.tb00474.x","article-title":"B cell differentiation factor in synovial fluid of patients with rheumatoid arthritis","volume":"78","author":"Al-Balaghi","year":"1984","journal-title":"Immunol Rew"},{"key":"10.1016\/j.joen.2014.08.013_bib43","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1056\/NEJM200103223441207","article-title":"Cytokine pathways and joint inflammation in rheumatoid arthritis","volume":"344","author":"Choy","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.joen.2014.08.013_bib44","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1016\/S0140-6736(12)60150-0","article-title":"Ulcerative colitis","volume":"380","author":"Ord\u00e1s","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.joen.2014.08.013_bib45","first-page":"1899","article-title":"The Cochrane review of physiotherapy interventions for ankylosing spondylitis","volume":"32","author":"Dagfinrud","year":"2005","journal-title":"J Rheumatol"},{"key":"10.1016\/j.joen.2014.08.013_bib46","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1136\/annrheumdis-2013-204627","article-title":"The global burden of rheumatoid arthritis: estimates from the Global Burden of Disease 2010 study","volume":"73","author":"Cross","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.joen.2014.08.013_bib47","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1186\/ar2669","article-title":"Epidemiological studies in incidence, prevalence, mortality, and comorbidity of the rheumatic diseases","volume":"11","author":"Gabriel","year":"2009","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.joen.2014.08.013_bib48","series-title":"Kelley\u2019s Textbook Of Rheumatology","author":"Firestein","year":"2013"},{"key":"10.1016\/j.joen.2014.08.013_bib49","doi-asserted-by":"crossref","first-page":"12489","DOI":"10.1073\/pnas.0504325102","article-title":"Variation in IL-1\u03b2 gene expression is a major determinant of genetic differences in arthritis aggressivity in mice","volume":"102","author":"Ohmura","year":"2005","journal-title":"Proc NatlAcad Sci U S A"},{"key":"10.1016\/j.joen.2014.08.013_bib50","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1002\/art.23592","article-title":"A broad analysis of IL1 polymorphism and rheumatoid arthritis","volume":"58","author":"Johnsen","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.joen.2014.08.013_bib51","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1056\/NEJMra1004965","article-title":"The pathogenesis of rheumatoid arthritis","volume":"365","author":"McInnes","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.joen.2014.08.013_bib52","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1177\/1759720X12438080","article-title":"The role of Rank ligand\/osteoprotegerin in rheumatoid arthritis","volume":"4","author":"Geusens","year":"2012","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"10.1016\/j.joen.2014.08.013_bib53","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1186\/ar2165","article-title":"Biology of RANK, RANKL, and osteoprotegerin","volume":"9","author":"Boyce","year":"2007","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.joen.2014.08.013_bib54","series-title":"Harrison\u2019s Principles Of Internal Medicine","author":"Longo","year":"2011"},{"key":"10.1016\/j.joen.2014.08.013_bib55","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nature01658","article-title":"Osteoclast differentiation and activation","volume":"423","author":"Boyle","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.joen.2014.08.013_bib56","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1210\/er.2007-0038","article-title":"Osteoimmunology: interactions of the bone and immune system","volume":"29","author":"Lorenzo","year":"2008","journal-title":"Endocr Rev"},{"key":"10.1016\/j.joen.2014.08.013_bib57","series-title":"Sleisenger and Fordtran\u2019s Gastrointestinal and Liver Disease","author":"Feldman","year":"2010"},{"key":"10.1016\/j.joen.2014.08.013_bib58","doi-asserted-by":"crossref","first-page":"e34349","DOI":"10.1371\/journal.pone.0034349","article-title":"Analysis of IL12B gene variants in inflammatory bowel disease","volume":"7","author":"Glas","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.joen.2014.08.013_bib59","doi-asserted-by":"crossref","DOI":"10.3402\/jom.v4i0.11829","article-title":"Rheumatoid arthritis and periodontitis: inflammatory and infectious connections. Review of the literature","volume":"4","author":"Persson","year":"2012","journal-title":"J Oral Microbiol"},{"key":"10.1016\/j.joen.2014.08.013_bib60","doi-asserted-by":"crossref","first-page":"3","DOI":"10.5051\/jpis.2012.42.1.3","article-title":"Effect of anti-rheumatic agents on periodontal parameters and biomarkers of inflammation: a systematic review and meta-analysis","volume":"42","author":"Han","year":"2012","journal-title":"J Periodontal Implant Sci"},{"key":"10.1016\/j.joen.2014.08.013_bib61","first-page":"656","article-title":"Synovial inflammation in active rheumatoid arthritis and psoriatic arthritis facilitates trapping of a variety of oral bacterial DNAs","volume":"24","author":"Moen","year":"2006","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.joen.2014.08.013_bib62","doi-asserted-by":"crossref","first-page":"2675","DOI":"10.1172\/JCI116884","article-title":"The antiinflammatory mechanism of methotrexate. Increased adenosine release at inflamed sites diminishes leukocyte accumulation in an in\u00a0vivo model of inflammation","volume":"92","author":"Cronstein","year":"1993","journal-title":"J Clin Invest"},{"key":"10.1016\/j.joen.2014.08.013_bib63","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/art.10148","article-title":"Guidelines for the management of rheumatoid arthritis: update","volume":"46","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.joen.2014.08.013_bib64","doi-asserted-by":"crossref","first-page":"14","DOI":"10.18553\/jmcp.2011.17.s9-b.S14","article-title":"Biologic agents in rheumatoid arthritis: an update for managed care professionals","volume":"17","author":"Agarwal","year":"2011","journal-title":"J Manag Care Pharm"},{"key":"10.1016\/j.joen.2014.08.013_bib65","first-page":"CD000067","article-title":"Azathioprine for maintaining remission of Crohn's disease","volume":"2","author":"Pearson","year":"2000","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.joen.2014.08.013_bib66","first-page":"1365","article-title":"Diagnosis and management of Crohn's disease","volume":"84","author":"Wilkins","year":"2011","journal-title":"Am Fam Physician"},{"key":"10.1016\/j.joen.2014.08.013_bib67","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/256495a0","article-title":"Pillars article: continuous cultures of fused cells secreting antibody of predefined specificity","volume":"256","author":"K\u00f6hler","year":"1975","journal-title":"Nature"},{"key":"10.1016\/j.joen.2014.08.013_bib68","doi-asserted-by":"crossref","first-page":"191","DOI":"10.3233\/HAB-1992-3405","article-title":"High-level expression and characterization of a mouse-human chimeric CD4 antibody with therapeutic potential","volume":"3","author":"Looney","year":"1992","journal-title":"Hum Antibodies Hybridomas"},{"key":"10.1016\/j.joen.2014.08.013_bib69","first-page":"81","article-title":"Immunological treatment of rheumatoid arthritis","volume":"8","author":"Sany","year":"1990","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.joen.2014.08.013_bib70","first-page":"165","article-title":"An anti-CD4 antibody for treatment of chronic inflammatory arthritis","volume":"32","author":"Emmrich","year":"1991","journal-title":"Agents Actions Suppl"},{"key":"10.1016\/j.joen.2014.08.013_bib71","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/0090-1229(91)90084-N","article-title":"Human anti-mouse antibody response induced by anti-CD4 monoclonal antibody therapy in patients with rheumatoid arthritis","volume":"59","author":"Horneff","year":"1991","journal-title":"Clin Immunol Immunopathol"},{"key":"10.1016\/j.joen.2014.08.013_bib72","first-page":"92","article-title":"Immunopathogenesis and treatment of rheumatoid arthritis","volume":"32","author":"Lipsky","year":"1992","journal-title":"J Rheumatol Suppl"},{"key":"10.1016\/j.joen.2014.08.013_bib73","first-page":"1348","article-title":"Chimeric CD7 monoclonal antibody therapy in rheumatoid arthritis","volume":"19","author":"Kirkham","year":"1992","journal-title":"J Rheumatol"},{"key":"10.1016\/j.joen.2014.08.013_bib74","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1002\/art.1780351207","article-title":"Inhibition of synovial fluid T cell proliferation by anti-CD5 monoclonal antibodies. A potential mechanism for their immunotherapeutic action in\u00a0vivo","volume":"35","author":"Verwilghen","year":"1992","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.joen.2014.08.013_bib75","first-page":"259","article-title":"Treatment of severe rheumatoid arthritis by anti-interleukin 6 monoclonal antibody","volume":"20","author":"Wendling","year":"1993","journal-title":"J Rheumatol"},{"key":"10.1016\/j.joen.2014.08.013_bib76","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1002\/art.1780360508","article-title":"Effects of administration of an anti-CD5 plus immunoconjugate in rheumatoid arthritis. Results of two phase II studies. The CD5 Plus Rheumatoid Arthritis Investigators Group","volume":"36","author":"Strand","year":"1993","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.joen.2014.08.013_bib77","first-page":"153","article-title":"Experience with a chimeric monoclonal anti-CD4 antibody in the treatment of refractory rheumatoid arthritis","volume":"11","author":"Moreland","year":"1993","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.joen.2014.08.013_bib78","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1097\/00006231-199308000-00007","article-title":"Comparison of 99Tcm-labelled specific murine anti-CD4 monoclonal antibodies and nonspecific human immunoglobulin for imaging inflamed joints in rheumatoid arthritis","volume":"14","author":"Kinne","year":"1993","journal-title":"Nucl Med Commun"},{"key":"10.1016\/j.joen.2014.08.013_bib79","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1002\/art.1780361206","article-title":"Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor alpha","volume":"36","author":"Elliott","year":"1993","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.joen.2014.08.013_bib80","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1002\/art.1780361008","article-title":"Chimeric CD4 monoclonal antibody cM-T412 as a therapeutic approach to rheumatoid arthritis","volume":"36","author":"Van der Lubbe","year":"1993","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.joen.2014.08.013_bib81","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/S0140-6736(94)90628-9","article-title":"Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor alpha\u00a0(cA2) versus placebo in rheumatoid arthritis","volume":"344","author":"Elliott","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.joen.2014.08.013_bib82","first-page":"335","article-title":"Immunologic responses to therapeutic biologic agents","volume":"18","author":"Purcell","year":"2008","journal-title":"J Investig Allergol Clin Immunol"},{"key":"10.1016\/j.joen.2014.08.013_bib83","unstructured":"Annex I. Summary of Product Characteristics. European Medicine Agency: Humira product information. Available at: http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/EPAR_-_Product_Information\/human\/000481\/WC500050870.pdf. Accessed June 29, 2014."},{"key":"10.1016\/j.joen.2014.08.013_bib84","unstructured":"Annex I. Summary of Product Characteristics. European Medicine Agency: Remicade product information. Available at: http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/EPAR_-_Product_Information\/human\/000240\/WC500050888.pdf. Accessed June 29, 2014."},{"key":"10.1016\/j.joen.2014.08.013_bib85","unstructured":"Annex I. Summary of Product Characteristics. European Medicine Agency: Enbrel product information. Available at: http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/EPAR_-_Product_Information\/human\/000262\/WC500027361.pdf. Accessed June 29, 2014."},{"key":"10.1016\/j.joen.2014.08.013_bib86","unstructured":"Annex I: Summary of Product Characteristics. European Medicine Agency: Cimzia product information. Available at: http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/EPAR_-_Product_Information\/human\/001037\/WC500069763.pdf. Accessed June 29, 2014."},{"key":"10.1016\/j.joen.2014.08.013_bib87","unstructured":"Annex I: Summary of Product Characteristics. European Medicine Agency: Simponi product information. Available at: http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/EPAR_-_Product_Information\/human\/000992\/WC500052368.pdf. Accessed June 29, 2014."},{"key":"10.1016\/j.joen.2014.08.013_bib88","unstructured":"Annex I: Summary of Product Characteristics. European Medicine Agency. Ilaris product information. Available at: http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/EPAR_-_Product_Information\/human\/001109\/WC500031680.pdf. Accessed June 29, 2014."},{"key":"10.1016\/j.joen.2014.08.013_bib89","unstructured":"Annex I: Summary of Product Characteristics. European Medicine Agency: Arcalyst product information. Available at: http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/EPAR_-_Product_Information\/human\/001047\/WC500026510.pdf. Accessed June 29, 2014."},{"key":"10.1016\/j.joen.2014.08.013_bib90","unstructured":"Annex I: Summary of Product Characteristics. European Medicine Agency: Kineret product information. Available at: http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/EPAR_-_Product_Information\/human\/000363\/WC500042310.pdf. Accessed June 29, 2014."},{"key":"10.1016\/j.joen.2014.08.013_bib91","unstructured":"Annex I: Summary of Product Characteristics. European Medicine Agency: Tysabri product information. Available at: http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/EPAR_-_Product_Information\/human\/000603\/WC500044686.pdf. Accessed June 29, 2014."},{"key":"10.1016\/j.joen.2014.08.013_bib92","unstructured":"Label and approval history: Enbrel. US Food and Drug Administration. Available at: http:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2012\/103795s5507lbl.pdf. Accessed June 29, 2014."},{"key":"10.1016\/j.joen.2014.08.013_bib93","unstructured":"Label and approval history: Humira. US Food and Drug Administration. Available at: http:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2012\/125057s232lbl.pdf. Accessed June 29, 2014.."},{"key":"10.1016\/j.joen.2014.08.013_bib94","unstructured":"Label and approval history: Remicade. US Food and Drug Administration. Available at: http:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2011\/103772s5295lbl.pdf. Accessed June 29, 2014."},{"key":"10.1016\/j.joen.2014.08.013_bib95","unstructured":"Label and approval history: Ilaris. US Food and Drug Administration. Available at: http:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2012\/125319s0054.pdf. Accessed June 29, 2014."},{"key":"10.1016\/j.joen.2014.08.013_bib96","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1902\/jop.2009.090015","article-title":"Anti-tumor necrosis factor alpha therapy and periodontal parameters in patients with rheumatoid arthritis","volume":"80","author":"Mayer","year":"2009","journal-title":"J Periodontol"},{"key":"10.1016\/j.joen.2014.08.013_bib97","doi-asserted-by":"crossref","first-page":"403","DOI":"10.4049\/jimmunol.160.1.403","article-title":"IL-1 and TNF antagonists inhibit the inflammatory response and bone loss in experimental periodontitis","volume":"160","author":"Assuma","year":"1998","journal-title":"J Immunol"},{"key":"10.1016\/j.joen.2014.08.013_bib98","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1034\/j.1600-051x.2001.028003233.x","article-title":"Soluble antagonists to interleukin-1 (IL-1) and tumor necrosis factor (TNF) inhibits loss of tissue attachment in experimental periodontitis","volume":"28","author":"Delima","year":"2001","journal-title":"J Clin Periodontol"},{"key":"10.1016\/j.joen.2014.08.013_bib99","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1086\/341778","article-title":"Inflammation and tissue loss caused by periodontal pathogens is reduced by interleukin-1 antagonists","volume":"186","author":"Delima","year":"2002","journal-title":"J Infect Dis"},{"key":"10.1016\/j.joen.2014.08.013_bib100","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/gt.2008.174","article-title":"AAV2\/1-TNFR: Fc gene delivery prevents periodontal disease progression","volume":"16","author":"Cirelli","year":"2009","journal-title":"Gene Ther"},{"key":"10.1016\/j.joen.2014.08.013_bib101","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1902\/jop.2009.080447","article-title":"Periodontal therapy reduces the severity of active rheumatoid arthritis in patients treated with or without tumor necrosis factor inhibitors","volume":"80","author":"Ortiz","year":"2009","journal-title":"J Periodontol"},{"key":"10.1016\/j.joen.2014.08.013_bib102","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.joen.2013.10.036","article-title":"Overlapping protective and destructive regulatory pathways in apical periodontitis","volume":"40","author":"Marton","year":"2014","journal-title":"J Endod"},{"key":"10.1016\/j.joen.2014.08.013_bib103","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1016\/j.joen.2011.08.007","article-title":"Cytokine analysis in lesions refractory to endodontic treatment","volume":"37","author":"Henriques","year":"2011","journal-title":"J Endod"},{"key":"10.1016\/j.joen.2014.08.013_bib104","doi-asserted-by":"crossref","first-page":"4681","DOI":"10.1128\/IAI.68.8.4681-4687.2000","article-title":"Toll-like receptor 4-deficient mice have reduced bone destruction following mixed anaerobic infection","volume":"68","author":"Hou","year":"2000","journal-title":"Infect Immun"},{"key":"10.1016\/j.joen.2014.08.013_bib105","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1177\/0022034512468757","article-title":"Inhibiting periapical lesions through AAV-RNAi silencing of cathepsin k","volume":"92","author":"Gao","year":"2013","journal-title":"J Dent Res"},{"key":"10.1016\/j.joen.2014.08.013_bib106","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1902\/annals.1998.3.1.327","article-title":"Genetic variations in cytokine expression: a risk factor for severity of adult periodontitis","volume":"3","author":"Kornman","year":"1998","journal-title":"Ann Periodontol"}],"container-title":["Journal of Endodontics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009923991400795X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009923991400795X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,7,17]],"date-time":"2023-07-17T04:44:52Z","timestamp":1689569092000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S009923991400795X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12]]},"references-count":106,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["S009923991400795X"],"URL":"https:\/\/doi.org\/10.1016\/j.joen.2014.08.013","relation":{},"ISSN":["0099-2399"],"issn-type":[{"value":"0099-2399","type":"print"}],"subject":[],"published":{"date-parts":[[2014,12]]}}}